REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmed, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Management Consulting Services | All Other Business Support Services
Full name: Pharmed, S.R.O. Profile Updated: July 29, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmed, S.R.O. is a company based in Slovakia, with its head office in Zilina. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on December 21, 2013. Pharmed, S.R.O. currently employs 5 - 9 (2025) people. In 2024, the company reported a net sales revenue increase of 35.16%. A growth of 71.68% was recorded in its total assets. The net profit margin of Pharmed, S.R.O. increased by 3.47% in 2024.

Headquarters
Sturova, 154/6
Zilina; Zilinsky; Postal Code: 01001

Contact Details: Purchase the Pharmed, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmed, S.R.O. report to view the information.
Registered Capital:
Purchase the Pharmed, S.R.O. report to view the information.
Financial Auditors:
Purchase the Pharmed, S.R.O. report to view the information.
Incorporation Date:
December 21, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmed, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
35.16%
Total operating revenue
37.02%
Operating profit (EBIT)
218.35%
EBITDA
130.08%
Net Profit (Loss) for the Period
259.94%
Total assets
71.68%
Total equity
42.44%
Operating Profit Margin (ROS)
4.79%
Net Profit Margin
3.47%
Return on Equity (ROE)
18.27%
Debt to Equity Ratio
-77.54%
Quick Ratio
0.42%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?